<?xml version="1.0" encoding="UTF-8"?>
<p>The species HEV-A consists of CV A2-A8, A10, A12, A14 and A16, and EV-A71 [
 <xref rid="B14-ijms-20-05201" ref-type="bibr">14</xref>]. The EV-A71 prototype (Br-CA-70 strain) was first described in 1969 in the USA from cases presenting with neurological disease [
 <xref rid="B24-ijms-20-05201" ref-type="bibr">24</xref>,
 <xref rid="B25-ijms-20-05201" ref-type="bibr">25</xref>]. Most of the HFMD cases worldwide are caused by HEV-A viruses and severe cases develop complications involving the CNS and respiratory tract [
 <xref rid="B26-ijms-20-05201" ref-type="bibr">26</xref>,
 <xref rid="B27-ijms-20-05201" ref-type="bibr">27</xref>]. HFMD is in most cases a self-limiting illness, however, a small proportion of cases (&lt;1%) develop life-threatening neurological and systemic complications [
 <xref rid="B19-ijms-20-05201" ref-type="bibr">19</xref>]. Additionally, other infections by HEV-A members are herpangina, AM, meningoencephalitis, acute flaccid paralysis, gastroenteritis, and encephalitis [
 <xref rid="B19-ijms-20-05201" ref-type="bibr">19</xref>,
 <xref rid="B27-ijms-20-05201" ref-type="bibr">27</xref>].
</p>
